Podcasts about Moa

ตลอดสองปีที่ผ่านมา รัฐบาลเพื่อไทยได้ผลักดันนโยบายเรือธงอย่าง ‘ซอฟต์พาวเวอร์' ด้วยงบประมาณมหาศาล อย่างไรก็ตาม หลังจากแพทองธาร ชินวัตร พ้นตำแหน่งนายกฯ คณะกรรมการยุทธศาสตร์ซอฟต์พาวเวอร์ก็สิ้นสภาพ แต่ยังมีงบประมาณปี 2569 ผ่านสภาไปแล้วกว่า 3,900 ล้านบาท ซึ่งจะกระจายไปยังหน่วยงานต่างๆ ที่เกี่ยวข้อง . ต่อมาสถานการณ์การเมืองไทยพลิกผันเมื่ออนุทิน ชาญวีรกูล ขึ้นดำรงตำแหน่งนายกฯ ซึ่งต้องยุบสภาภายใน 4 เดือนตาม MOA ระหว่างพรรคภูมิใจไทยกับพรรคประชาชน ทำให้รัฐบาลต้องให้ความสำคัญกับนโยบายเร่งด่วน เช่น ปัญหาชายแดนไทย-กัมพูชา และเศรษฐกิจ โดยเตรียมนำนโยบายคนละครึ่งกลับมาใช้เพื่อกระตุ้นการจับจ่ายของประชาชน ด้วยงบประมาณ 25,000 ล้านบาท . ส่วนนโยบายซอฟต์พาวเวอร์นั้น คาดว่าอาจจะมีการสานต่อ แต่จนถึงตอนนี้ยังไม่เห็นทิศทางชัดเจน 101 In Focus สัปดาห์นี้ จึงชวนย้อนสำรวจว่าตลอดระยะเวลาที่ผ่านมานโยบายซอฟต์พาวเวอร์ต้องใช้ต้นทุนมากแค่ไหน ได้ผลลัพธ์ตามเป้าหมายหรือไม่ และควรเดินหน้าต่ออย่างไรให้ยั่งยืน .

อนุทิน ชาญวีรกูล หัวหน้าพรรคภูมิใจไทย ได้รับการโปรดเกล้าฯ เป็นนายกรัฐมนตรีคนที่ 32 ของประเทศ ด้วยคะแนนเสียงสนับสนุนจากสภาผู้แทนราษฎรถึง 311 เสียง ถือเป็นการเปลี่ยนผ่านครั้งสำคัญที่ตัดขาดจากนโยบายเศรษฐกิจที่เคยเน้นการกระตุ้นการใช้จ่ายภาครัฐและการส่งเสริมการส่งออก เมื่อผู้นำคนใหม่ประกาศนโยบายบริหารประเทศที่มุ่งเน้นความสมดุลในทุกมิติ ทั้งเศรษฐกิจ สังคม และการเมือง เพื่อสร้างความมั่นคงและความยั่งยืนให้กับชาติ อย่างไรก็ตาม สังคมยังคงจับตาอย่างใกล้ชิดว่า รัฐบาล 4 เดือนของพรรคภูมิใจไทย จะทำตาม MOA ที่สัญญาไว้กับพรรคประชาชนหรือไม่ ชวนติดตามและวิเคราะห์ไปพร้อมกัน

Send us a textRick Olson's path from crafting architectural metalwork for the homes of tech billionaires to revolutionizing firearms manufacturing exemplifies American innovation at its finest. In this candid conversation, Rick pulls back the curtain on the precision engineering that sets his barrels apart from anything else on the market.With remarkable transparency, Rick shares how he taught himself machining from scratch in 2011, developing a single-point cut rifling process that took two years to perfect but produces pistol barrels with unmatched accuracy. "I can take anybody else's barrel on the planet and cut their group size in half," he states confidently – a bold claim backed by years of meticulous development and testing. His newly patented 12-groove rifling system for 300 Blackout barrels solves the fundamental problem of gas blow-by with subsonic ammunition, achieving sub-MOA accuracy at distances where competitors fall apart.Beyond the technical innovations, Rick offers invaluable insights into navigating the volatile firearms industry as a business owner. From nearly losing everything during the post-2016 "Trump slump" to building a manufacturing operation that now employs over 40 people and runs 24/7, his journey highlights both the rewards and pitfalls of entrepreneurship in this space. He addresses head-on the economic pressures squeezing firearms manufacturers – rising costs but stagnant prices – while sharing strategies for sustainable growth.The conversation takes a thoughtful turn as Rick discusses the current state of Second Amendment advocacy and the challenging legislative environment in Washington state. His perspective on education-focused approaches to changing public perception offers a refreshing alternative to the often polarized firearms discourse.Whether you're fascinated by precision manufacturing, considering starting your own business, or simply interested in firearms innovation, this episode delivers insights you won't find anywhere else. Tune in to discover how determination, technical excellence, and a passion for quality have established Rick Olson as a respected innovator in American firearms manufacturing.Support the showFind out more about Big Tex Ordnance at bigtexordnance.com

ในที่สุดศาลรัฐธรรมนูญก็ชี้ชัดแล้วว่า ในการจัดทำรัฐธรรมนูญฉบับใหม่ทำประชามติ 2 ครั้งได้ แต่ต้องถาม 3 เรื่อง (เรื่องที่ 1 และ 2 ถามพร้อมกันได้) ปมปัญหานี้จึงถูกคลี่คลายไป แต่ศาลกลับเพิ่มปมปัญหาใหม่ขึ้นมาแทน . “รัฐสภาไม่อาจให้ประชาชนเลือกผู้ร่างรัฐธรรมนูญได้โดยตรง” ถ้อยความนี้จากคำวินิจฉัยเมื่อวันที่ 10 กันยายน 2568 สามารถตีความได้หรือไม่ว่า ประชาชนไม่สามารถเลือกตั้ง สสร. มาร่างรัฐธรรมนูญใหม่ได้ แล้วคำวินิจฉัยนี้จะส่งผลต่อ MOA ของพรรคประชาชนและภูมิใจไทยอย่างไร ภายในระยะเวลา 4 เดือน กระบวนการร่างรัฐธรรมนูญใหม่จะเริ่มต้นได้หรือไม่ . ชวนคิดชวนคุยในรายการ 101 POSTSCRIPT คุยข่าวนอกสคริปต์ผ่านมุมมองโลกวิชาการและสื่อสารมวลชนแบบ ‘วันโอวัน' . ร่วมคุยโดย วิสุทธิ์ คมวัชรพงศ์ | เข็มทอง ต้นสกุลรุ่งเรือง | อินทร์แก้ว โอภานุเคราะห์กุล

What does it take to challenge centuries of tradition and shift an entire culture's relationship with alcohol? In this episode, I sit down with Moa Gürbüzer, a former social worker and family therapist who saw firsthand how alcohol harms families and communities. Rather than staying in the therapy room, Moa decided to tackle the issue at its roots: our cultural norms and rituals around drinking.At the age of 55, she founded Oddbird, a Swedish winery dedicated to producing world-class, non-alcoholic wines. Partnering with leading oenologists and more than 100 vineyards, Moa has turned skepticism into admiration—her wines are now served in Michelin-starred restaurants, featured at the Nobel Prize after-party, and even gifted to Porsche owners in Sweden.Moa shares her journey from being dismissed as an “outsider” to building a respected brand that blends craftsmanship, science, and social purpose. We talk about why shame is at the core of drinking culture, how women supporting women can accelerate change, and why failure should be celebrated as part of the entrepreneurial process.This is a conversation about innovation, resilience, and rewriting the rules—not only for the wine industry, but for how we celebrate, connect, and care for one another.This season of our podcast is brought to you by TD Canada Women in Enterprise. TD is proud to support women entrepreneurs and help them achieve success and growth through its program of educational workshops, financing and mentorship opportunities! Please find out how you can benefit from their support! Visit: TBIF: thebrandisfemale.com // TD Women in Enterprise: td.com/ca/en/business-banking/small-business/women-in-business // Follow us on Instagram: instagram.com/thebrandisfemale

Här kan du lyssna på en AI-genererad uppläsning av följande artikel: Moa, 23, vägrade byta skift – prisas som facklig hjälte

Dr. Pedro Barata and Dr. Rana McKay discuss the integration of innovative advances in molecular imaging and therapeutics to personalize treatment for patients with renal cell and urothelial carcinomas. TRANSCRIPT Dr. Pedro Barata: Hello, I'm Dr. Pedro Barata, your guest host of By the Book, a podcast series featuring insightful conversations between authors and editors of the ASCO Educational Book. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. Now, we all know the field of genitourinary cancers (GU) is evolving quite rapidly, and we have new innovations in molecular imaging as well as targeted therapeutics. Today's episode will be exploring novel approaches that are transforming the management of renal cell and urothelial carcinomas and also their potential to offer a more personalized treatment to patients. For that, joining for today's discussion is Dr. Rana McKay, a GU medical oncologist and professor at University of California San Diego. Dr. McKay will discuss her recently published article titled, “Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor-Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas.”  Our full disclosures are available in the transcript of this episode.  And with that, Rana McKay, great to have you on the podcast today. Dr. Rana McKay: Oh, thank you so much, Dr. Barata. It's really wonderful to be here with you. So, thanks for hosting. Dr. Pedro Barata: No, thanks for taking the time, and I'm looking forward to this conversation. And by the way, let me start by saying congrats on a great article in the Educational Book. Really super helpful paper. I'm recommending it to a lot of the residents and fellows at my own institution. I would like to first ask you to kind of give our listeners some context of how novel approaches in the molecular imaging as well as targeted therapeutics are actually changing the way we're managing patients with GU, but specifically with renal cell carcinoma and urothelial carcinoma. So, what are the areas you would call out as like being big areas for innovation in this context, and why are they important? Dr. Rana McKay: Very good question. And I think this is really what this article highlights. It highlights where are we going from an imaging diagnostics standpoint? Where are we going from a therapeutic standpoint? And I think if we have to step back, from the standpoint of diagnostics, we've seen PET imaging really transform diagnostics in prostate cancer with the advent of PSMA PET imaging, and now PSMA PET imaging is used as a biomarker for selection for theranostics therapy. And so, we're starting to see that enter into the RCC landscape, enter into the urothelial cancer landscape to a lesser extent. And I think it's going to potentially be transformative as these tools get more refined. I think when we think about therapeutics, what's been transformative most recently in the renal cell carcinoma landscape has been the advent of HIF2α inhibition to improve outcomes for patients. And we have seen the approval of belzutifan most recently that has reshaped the landscape. And now there's other HIF2α inhibitors that are being developed that are going to be further important as they get refined. And lastly, I think when we think about urothelial carcinoma, the greatest transformation to treatment in that context has been the displacement of cisplatin and platinum-based chemotherapy as a frontline standard with the combination of enfortumab vedotin plus pembrolizumab. And we've seen antibody-drug conjugates really reshape treatment and tremendously improve outcomes for patients. So, I think those are the three key areas of interest. Dr. Pedro Barata: So with that, let's focus first on the imaging and then we'll get to the therapeutic area. So, we know there's been a paradigm shift, really, when prostate-specific targets emerged as tracers for PET scanning. And so, we now commonly use prostate-specific membrane antigen, or PSMA-based PET scanning, and really transform how we manage prostate cancer. Now, it appears that we're kind of seeing a similar wave in renal cell carcinoma with the new radiotracer against the target carbonic anhydrase IX. What can you tell us about this? And is this going to be available to us anytime soon? And how do you think that might potentially change the way we're managing patients with RCC today? Dr. Rana McKay: First, I'll step back and say that in the context of PSMA PET imaging, we have actually been able to better understand RCC as well. So, we know that PSMA is expressed in the neovasculature of tumors, and it can actually be used to detect renal cell carcinoma tumors. It has a detection rate of about 84% when used for detection. And so, you know, I don't think it's just restricted to carbonic anhydrase IX, but we will talk about that. So, PSMA expressed in the neovasculature has a detection rate of around 84%, particularly if we're looking at clear cell RCC. CAlX is overexpressed in clear cell RCC, and it's actually used in diagnosing renal cell carcinoma when we think of CAlX IHC for diagnosing clear cell RCC. And now there are CAlX PET tracers. The first foray was with the ZIRCON study that was actually an interestingly designed study because it was designed to detect the likelihood of PET imaging to identify clear cell RCC. So, it was actually used in the early diagnostics setting when somebody presents with a renal mass to discriminate that renal mass from a clear cell versus a non-clear cell, and it was a positive study. But when I think about the potential application for these agents, you know, I think about the entire landscape of renal cell carcinoma. This is a disease that we do treat with metastasis-directed therapy. We have certainly seen patients who've undergone metastasectomy have long, durable remissions from such an approach. And I think if we can detect very early onset oligometastatic disease where a metastasis-directed therapy or SABR could be introduced - obviously tested in a trial to demonstrate its efficacy - I think it could potentially be transformative. Dr. Pedro Barata: Wonderful. It's a great summary, and I should highlight you are involved in some of those ongoing studies testing the performance of this specific PET scanning for RCC against conventional imaging, right? And to remind the listeners, thus far, for the most part, we don't really do FDG-PET for RCC. There are some specific cases we do, but in general, they're not a standard scanning. But maybe that will change in the future. Maybe RCC will have their own PSMA-PET. And to your point, there's also emerging data about the role of PSMA-PET scanning in RCC as well, as you very elegantly summarized. Wonderful. So, let me shift gears a little bit because you did, in your introduction, you did highlight a novel MOA that we have in renal cell carcinoma, approved for use, initially for VHL disease, and after that for sporadic clear cell renal cell carcinoma. We're talking about hypoxia-inducible factor 2-alpha inhibitors, or HIF2α inhibitors, such as belzutifan. But there's also others coming up. So, as a way to kind of summarize that, what can you tell us about this breakthrough in terms of therapeutic class, this MOA that got to our toolbox of options for patients with advanced RCC? Tell us a little bit what is being utilized currently in the management of advanced RCC. And where do you see the future going, as far as, is it moving early on? Is it getting monotherapy versus combinations? Maybe other therapies? What are your thoughts about that? What can you tell us about it? Dr. Rana McKay: Belzutifan is a first-in-class HIF2α inhibitor that really established clinical validation for HIF2α as a therapeutic target. When we think about the activity of this agent, the pivotal LITESPARK-005 trial really led to the approval of belzutifan in patients who were really heavily pretreated. It was patients who had received prior IO therapy, patients who had received prior VEGF-targeted therapy. And in the context of this study, we saw a median PFS of 5.6 months, and there did seem to be a tail on the curve when you looked at the 12-month PFS rate with belzutifan. It was 33.7% compared to 17.6% with everolimus. And then when we look at the response rate, it was higher with belzutifan on the order of 22-23%, and very low with everolimus, as we've previously seen. I think one of the Achilles heels of this regimen is the primary PD rate, which was 34% when used in later line. There are multiple studies that are testing belzutifan in combination across the treatment landscape. So, we have LITESPARK-011, which is looking at the combination of belzutifan plus lenvatinib in the second-line setting. We've got the MK-012 [LITESPARK-012] study, which is looking at belzutifan in various combinations in the frontline setting. So there is a combination with IO plus belzutifan. And so this is also being looked at in that context. And then we also have the LITESPARK-022 study, which is looking at pembrolizumab with belzutifan in the adjuvant setting. So there's a series of studies that will be exploring belzutifan really across the treatment landscape. Many of these studies in combination. Additionally, there are other HIF2α inhibitors that are being developed. We have casdatifan, which is another very potent HIF2α inhibitor. You know, I think pharmacologically, these are different agents. There's a different half-life, different dosing. What is going to be the recommended phase 3 dose for both agents, the EPO suppression levels, the degree of EPO suppression, and sustainability of EPO suppression is very different. So, I think we've seen data from casdatifan from the ARC-20 trial from monotherapy with a respectable response rate, over 30%, primary PD rate hovering just around 10%.  And then we've also seen data of the combination of casdatifan with cabozantinib as well that were recently presented this year. And that agent is also being tested across the spectrum of RCC. It's being looked at in combination with cabozantinib in the PEAK-1 study, and actually just at the KCRS (Kidney Cancer Research Summit), we saw the unveiling of the eVOLVE-RCC trial, which is going to be looking at a volrustomig, which is a PD-1/CTLA-4 inhibitor plus casdatifan compared to nivo-ipi in the frontline setting.  So, we're going to see some competition in this space of the HIF2α inhibitors. I think when we think of mechanism of action in that these are very potent, not a lot of off-target activity, and they target a driver mutation in the disease. And that driver mutation happens very early in the pathogenesis. These are going to be positioned much earlier in the treatment landscape. Dr. Pedro Barata: All these studies, as you're saying, look really promising. And when we talk about them, you mentioned a lot of combinations. And to me, when I think of these agents, it makes a lot of sense to combine because there's not a lot of overlapping toxicities, if you will. But perhaps for some of our listeners, who have not used HIF2α inhibitors in practice yet, and they might be thinking about that, what can you tell us about the safety profile? How do you present it to your patients, and how do you handle things like hypoxia or anemia? How do you walk through the safety profile and tolerability profile of those agents like belzutifan? Dr. Rana McKay: I think these drugs are very different than your traditional TKIs, and they don't cause the classic symptoms that are associated with traditional TKIs that many of us are very familiar with like the rash, hand-foot syndrome, hypertension, diarrhea. And honestly, these are very nuanced symptoms that patients really struggle with the chronicity of being on a chronic daily TKI. The three key side effects that I warn patients about with HIF2α inhibitors are: (1) fatigue; (2) anemia; and (3) hypoxia and dysregulation in the ability to sense oxygen levels. And so, many of these side effects - actually, all of them - are very dose-dependent. They can be very well-managed. So, we can start off with the anemia. I think it's critically important before you even start somebody on belzutifan that you are optimizing their hemoglobin and bone marrow function. Make sure they don't have an underlying iron deficiency anemia. Make sure they don't have B12 or folate deficiency. Check for these parameters. Many patients who have kidney cancer may have some hematuria, other things where there could be some low-level blood loss. So, make sure that those are resolved or you're at least addressing them and supplementing people appropriately. I monitor anemia very closely every 3 to 4 weeks, at least, when people start on these medications. And I do initiate EPO, erythropoietin, should the anemia start to worsen. And I typically use a threshold of around 10g/dL  for implementing utilization of an EPO agent, and that's been done very safely in the context of the early studies and phase 3 studies as well. Now, with regards to the hypoxia, I think it's also important to make sure that you're selecting the appropriate individual for this treatment. People who have underlying COPD, or even those individuals who have just a very high burden of disease in their lung, lymphangitic spread, pleural effusions, maybe they're already on oxygen - that's not an ideal candidate for belzutifan. Something that very easily can be done in the clinic before you think about initiating somebody on this treatment, and has certainly been integrated into some of the trials, is just a 6-minute walk test. You know, have the patient walk around the clinic with one of the MAs, one of the nurses, put the O2 sat on [measuring oxygen saturation], make sure they're doing okay. But these side effects, like I said, are very dose-dependent. Typically, if a patient requires, if the symptoms are severe, the therapy can be discontinued and dose reduced. The standing dose is 120 mg daily, and there's two dose reductions to 80 mg and 40 mg should somebody warrant that dose modification. Dr. Pedro Barata: This is relatively new, right? Like, it was not that we're used to checking oxygen levels, right? In general, we're treating these patients, so I certainly think there's a learning curve there, and some of the points that you highlight are truly critical. And I do share many of those as well in our practice. Since I have you, I want to make sure we touch base on antibody-drug conjugates as well. It's also been a hot area, a lot of developments there. When I think of urothelial carcinoma and renal cell carcinoma, I see it a little bit different. I think perhaps in urothelial carcinoma, antibody-drug conjugates, or ADCs, are somewhat established already. You already mentioned enfortumab vedotin. I might ask you to expand a little bit on that. And then in renal cell carcinoma, we have some ADCs as well that you include in your chapter, and that I would like you to tell us what's coming from that perspective. So, tell us a little bit about how do you see ADCs in general for GU tumors, particularly UC and RCC? Tell us a little bit about the complexity or perhaps the challenges you still see. At the same time, tell us about the successes. Dr. Rana McKay: Stepping back, let's just talk about like the principles and design of ADCs. So, most ADCs have three components. There's a monoclonal antibody that typically targets a cell surface antigen, which is conjugated by a linker, which is the second component, to a payload drug. And typically, that payload drug has been chemotherapy, whether it be topoisomerase or whether it be MMAE or other chemotherapeutic. We can start in the RCC space. There's been multiple antibody-drug conjugates that have been tested. There's antibody-drug conjugates to CD70, which is expressed on clear cell RCC. There's been antibody-drug conjugates to ENPP3, which is also expressed on RCC. There's antibody-drug conjugates to CDH6. And they have different payloads, like I said, whether it be topoisomerase I or other microtubule inhibitors. Now, when we think about kidney cancer, we don't treat this disease with chemotherapy. This disease is treated with immunotherapy. It is treated with treatments that target the VEGF pathway and historically has not been sensitive to chemo. So, I think even though the targets have been very exciting, we've seen very underwhelming data regarding activity, and in some context, seen increased toxicity with the ADCs. So, I think we need to tread lightly in the context of the integration and the testing of ADCs in RCC. We just came back from the KCRS meeting, and there was some very intriguing data about a c-Kit ADC that's being developed for chromophobe RCC, which is, you know, a huge unmet need, these variant tumors that really lack appropriate therapeutics. But I just caution us to tread lightly around how can we optimize the payload to make sure that the tumor that we're treating is actually sensitive to the agent that's targeting the cell kill. So, that's a little bit on the ADCs in RCC. I still think we have a long way to go and still in early testing. Now, ADCs for UC are now the standard of care. I think the prototypical agent, enfortumab vedotin, is a nectin-4-directed ADC that's conjugated to an MMAE payload and was the first ADC approved for advanced urothelial, received accelerated approval following the EV-201 trial, which was basically a multicenter, single-arm study that was investigating EV in cisplatin-ineligible patients with advanced urothelial carcinoma, and then ultimately confirmed in the EV-301 study as well. And so, that study ended up demonstrating the support superiority of EV from an overall survival standpoint, even PFS standpoint. Building on that backbone is the EV-302 study, which tested EV in combination with pembrolizumab versus platinum-based chemotherapy in the frontline setting. And that was a pivotal, landmark study that, like I said, has displaced platinum therapy as a frontline treatment for people with advanced urothelial carcinoma. And when we think about that study and the median overall survival and just how far we've come in urothelial cancer, the median OS with EV-pembro from that trial was 31 and a half months. I mean, that's just incredible. The control arm survival was 16 and a half months. The hazard ratio for OS, 0.47. I mean this is why when this data was presented, it was literally a standing ovation that lasted for several minutes because we just haven't seen data that have looked that good. And there are other antibody-drug conjugates that are being tested. We've all been involved in the saga with sacituzumab govitecan, which is a trophoblast cell surface antigen 2 (Trop-2) targeted ADC with a topoisomerase I payload. It was the second ADC to receive approval, but then that approval was subsequently withdrawn when the confirmatory phase 3 was negative, the TROPiCS-04 trial. So, approval was granted based off of the TROPHY-U-01, single-arm, phase 2 study, demonstrating a response rate of around 28% and a PFS of, you know, about 5 and a half months. But then failure to show any benefit from an OS standpoint. And I think there's a lot of controversy in the field around whether this agent still has a role in advanced urothelial carcinoma. And I think particularly for individuals who do not have molecular targets, like they're not HER2-amplified or have HER2-positivity or FGFR or other things like that. Dr. Pedro Barata: Fantastic summary, Rana. You were talking about the EV, and it came to mind that it might not be over, right, for the number of ADCs we use in clinical practice in the near future. I mean, we've seen very promising data for ADC against the HER2, right, and over-expression. It also can create some challenges, right, in the clinics because we're asking to test for HER2 expression. It's almost like, it's not exactly the same to do it in breast cancer, but it looks one more time that we're a little bit behind the breast cancer field in a lot of angles. And also has vedotin as a payload. Of course, I'm referring to disitamab vedotin, and there's very elegant data described by you in your review chapter as well. And it's going to be very interesting to see how we sequence the different ADCs, to your point as well. So, before we wrap it up, I just want to give you the opportunity to tell us if there's any area that we have not touched, any take-home points you'd like to bring up for our listeners before we call it a day. Dr. Rana McKay: Thank you so much. I have to say, you know, I was so excited at ASCO this year looking at the GU program. It was fantastic to see the progress being made, novel therapeutics that really there's a tremendous excitement about, not just in RCC and in UC, but also in prostate cancer, thinking about the integration of therapies, not just for people with refractory disease that, even though our goal is to improve survival, our likelihood of cure is low, but also thinking about how do we integrate these therapies early in the treatment landscape to enhance cure rates for patients, which is just really spectacular. We're seeing many of these agents move into the perioperative setting or in combination with radiation for localized disease. And then the special symposium on biomarkers, I mean, we've really come a long, long way. And I think that we're going to continue to evolve over the next several years. I'm super excited about where the field is going in the treatment of genitourinary malignancies. Dr. Pedro Barata: Oh, absolutely true. And I would say within the Annual Meeting, we have outstanding Educational Sessions. And just a reminder to the listeners that actually that's where the different teams or topics for the Educational Book chapters come from, from actually the educational sessions from ASCO. And your fantastic chapter is an example of that, right, focusing on advanced GU tumors. So, thank you so much, Rana, for taking the time, sharing your insights with us today on the podcast. It was a fantastic conversation as always. Dr. Rana McKay: My pleasure. Thanks so much for having me, Dr. Barata. Dr. Pedro Barata: Of course.  And thank you to our listeners for your time today. You will find the link to the article discussed today in the transcript of this episode. I also encourage you to check out the 2025 ASCO Educational Book. You'll find an incredible wealth of information there. It's free, available online, and you'll find, hopefully, super, super important information on the key science and issues that are shaping modern oncology, as we've heard from Dr. McKay and many other outstanding authors. So, thank you, everyone, and I hope to see you soon. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:        Dr. Pedro Barata @PBarataMD Dr. Rana McKay @DrRanaMcKay Follow ASCO on social media:        @ASCO on X (formerly Twitter)        ASCO on Bluesky       ASCO on Facebook        ASCO on LinkedIn        Disclosures:     Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck  Dr. Rana McKay: Consulting or Advisory Role: Janssen, Novartis, Tempus, Pfizer, Astellas Medivation, Dendreon, Bayer, Sanofi, Vividion, Calithera, Caris Life Sciences, Sorrento Therapeutics, AVEO, Seattle Genetics, Telix, Eli Lilly, Blue Earth Diagnostics, Ambrx, Sumitomo Pharma Oncology, Esiai, NeoMorph, Arcus Biosciences, Daiichi Sankyo, Exelixis, Bristol Myers Squibb, Merck, Astrazeneca, Myovant Research Funding (Inst.): Bayer, Tempus, AstraZeneca, Exelixis, Bristol Myers Squibb, Oncternal Therapeutics, Artera    

Magazine de ocio, actualidad y cultura de Vigo.En Hoy por Hoy Vigo hemos tenido al experto aeroportuario Rodrigo Lagoa para analizar el adiós de Ryanair a Galicia. También se pasó Manuel Martín para hablarnos de las 200 concentraciones por la Sanidad Pública en Moaña. Repasamos lo más viral en las redes sociales con Antía Paz en Tirando la Red y también tuvimos una nueva edición de Todo lo que usted siempre quiso saber sobre la historia de Vigo sobre Praia América. En el Cónclave Celeste analizamos el Celta-Girona y también tuvimos Academia Postal y Vithas Vigo. 

La Ventana Metropolitana.Varias protestas convocadas en el área metropolitana de Vigo para pedir la expulsión del equipo ciclista de Israel de La Vuelta. Entrevista a Nidia Arévalo, alcaldesa de Mos, por la etapa de La Vuelta a España que termina en el Castro de Herville. Protestas por el recorte de profesorado en el CEIP Reibón en Moaña o el CEIP Igrexa en Redondela.  

La Ventana Metropolitana.Prisión para el hombre detenido por matar a una trabajadora del SAF en O Porriño. Moaña conmemora con una manifestación sus 200 semanas de movilizaciones en defensa de la sanidad pública. El Festival de Poesía no Condado celebra su edición 37 con dos días de actividades.

Kvar fredag før sola skin sit ein gjeng med menn og drikk kaffi og ber på Espresso House på Moa. Vidar Aasebø, saman med fleire, startar dagen kl. 0700 med morgonbøn, prat og kaffi. Ein viktig møtestad for både prat og omsorg. Høyr heile intervjuet med Vidar Aasebø.

Kulturkanonen är äntligen här, men Moa kommer sakna Lars Trägårdh. Allt om bob hunds sista spelning och som utlovat bjuder Nanna på en spökhistoria Lyssna på alla avsnitt i Sveriges Radio Play.

Wade takes the PWS Mark 114 Mod 2-M (14.5” pin & weld, 6mm ARC) to the range to see if this piston-driven rifle really delivers on its sub-MOA guarantee.In this episode:Full breakdown of Wade's test setup & stock swapGroup size results across 65–108gr loadsWhy some ammo shines and others fall flatSuppressor settings, buffer weight talk, and long-term testing plansThe verdict? The Mark 114 proves to be a legit sub-MOA rifle — but with some quirks you'll want to know before buying.Got one yourself? Let us know what ammo has worked best for you.

In dieser Folge nehmen wir euch mit auf eine besondere Reise in die Welt von Steffen Prase, besser bekannt als MOA fire“.

Taylor Swift announced new music and Labubu fans are getting a whole store at the MOA! Stormer's got the latest on Pamela Anderson's homemade pickles! The blinds are full of the latest on Jeremy Renner's dating life. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Vous êtes déjà en train de programmer vos prochaines vacances ? Pour les amoureux d'histoires et de mystères, certaines destinations insolites peuvent vous permettre de vivre des expériences fascinantes et surtout inoubliables… La référence en la matière reste certainement l'île de Pâques à 3500 kilomètres des côtes chilienne. Sur cette île, vous trouverez des statues monumentales en pierre, qu'on appelle Moaï, toutes tournées vers l'intérieur de l'Île. Encore aujourd'hui, de nombreuses questions restent sans réponse. On ne connait toujours pas, avec certitude, la symbolique de ces statues dont certaines comportent des messages codés que personne n'a encore n'a réussi à déchiffrer. Il semblerait qu'elle représente des chefs ou encore des divinités, mais encore une fois, rien n'est sûr. A-t-on d'autres destinations dans la même veine ? Est-ce qu'il y a des lieux mystérieux qu'on ne peut pas visiter ? Écoutez la suite de cet épisode de "Maintenant vous savez". Un podcast Bababam Originals, écrit et réalisé par Joanne Bourdin. À écouter aussi : ⁠⁠Comment vaincre sa peur de l'eau ?⁠⁠ ⁠⁠Qu'est-ce que le "quiet vacationing", cette pratique controversée ?⁠⁠ ⁠⁠Qu'est-ce que le R-Bombing, cette tendance amoureuse toxique ?⁠⁠ Retrouvez tous les épisodes de ⁠"Maintenant vous savez".⁠ Suivez Bababam sur ⁠Instagram⁠. première diffusion le 14/08/2024 Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we discuss Colossal bringing back the Moa, how some veterinarians can scam people, and huge lobsters that deserve to live. Enjoy! (TWT 179)Chubbies: Your new wardrobe awaits! Get $10 off Chubbies at https://www.chubbiesshorts.com/wild #chubbiespod Smalls: For a limited time only, get 60% off your first order PLUS free shipping when you head to https://smalls.com/WILD. Magic Mind: Take advantage of this launch and get 25% off Magic Mind Performance Gummies with code WILD25 or go to https://magicmind.com/wildgmGet More Wild Times Podcast Episodes:https://podcasters.spotify.com/pod/show/wildtimespod/subscribehttps://www.patreon.com/wildtimespodMore Wild Times:Instagram: http://instagram.com/wildtimespodTikTok: https://www.tiktok.com/@wildtimespodcastFacebook: https://www.facebook.com/wildtimespod/X: https://x.com/wildtimespodDiscord: https://discord.gg/ytzKBbC9DbWebsite: https://wildtimes.club/Merch: https://thewildtimespodcast.com/merchBattle Royale Card Game: https://wildtimes.club/brOur Favorite Products:https://www.amazon.com/shop/thewildtimespodcastMusic/Jingles by: www.soundcloud.com/mimmkeyThis video may contain paid promotion.#ad #sponsored #forrestgalante #extinctoralive #podcast

Een nieuw Nerdland maandoverzicht! Met deze maand: De Ichtyosaurus! Dromen en Kaas! Luiaards! MRI-machines! Zwaartekrachtsgolven! Een nieuw celorganel! En meer... Shownotes: https://podcast.nerdland.be/nerdland-maandoverzicht-augustus-2025/ Gepresenteerd door Lieven Scheire met Natha Kerkhofs, Hetty Helsmoortel, Bart van Peer, Jeroen Baert en Els Aerts. Opname, montage en mastering door Jens Paeyeneers en Els Aerts. (00:00:00) Intro (00:01:55) Humanoid robot sport games in Beijing (00:10:23) Collosal wil nu ook de Moa terugbrengen (00:16:01) Opnieuw een ruimte-object van buiten ons zonnestelsel bezoek (00:23:11) Zwaartekrachtgolven onthullen zwaarste zwarte gaten fusie tot nu toe (00:29:43) Ichtyosaurus gebruikt “stealth” vleugels (00:37:48) Kaas kan je dromen beïnvloeden (00:46:22) Vele neurowetenschappers denken dat het technische mogelijk wordt om herinneringen uit dode hersenen te halen (00:55:43) Man gebruikt spreeuw als data-opslag (01:01:25) Nieuw celorganel ontdekt! (01:07:03) Nieuw object aan de rand van ons zonnestelsel verkleint de kans op Planeet X (01:10:41) De tekenen van buitenaards leven op K2-18b zijn precies verdwenen… (01:13:33) SILICON VALLEY NEWS (01:13:47) Veo 3 video generator van Google (01:16:11) Anthropic liet zijn AI fysieke boeken lezen. Die wel eerst stukgeknipt moesten worden. (01:20:44) Nvidia haalt beveiligingsadvies bij Intrigrity waar Inti De Keuckelaere werkt! (01:23:01) Boeing en Nasa willen verder met starliner (01:24:27) Robot voert operatie uit zonder menselijke hulp (01:31:53) Vergeten vermelden over Space act: hackatons cassini.eu (01:33:55) De aarde draait plots sneller: dagen worden korter (01:36:28) Verborgen prompt injection in wetenschappelijke papers probeert betere review te krijgen van AI systemen (01:40:02) Beelden bewijzen: een luiaard kan dan toch scheten laten (01:44:30) Modetrend bij chimpansees: ze steken grassprietjes in hun gat (01:51:06) Man met zware metalen ketting sterft in MRI machine (01:56:33) Florida bestrijdt pythons met robotkonijnen (01:57:56) Nog een paar tips! (01:58:01) Human op BBC iPlayer (02:01:58) Detectorists staat op VRT Max! (02:03:00) Tom Lehrer is overleden (02:05:29) Lieven en Hetty gingen op bezoek bij Formule 1 (02:15:12) Recalls en eigen promo (02:19:13) Sponsor Syntra

Vous êtes déjà en train de programmer vos prochaines vacances ? Pour les amoureux d'histoires et de mystères, certaines destinations insolites peuvent vous permettre de vivre des expériences fascinantes et surtout inoubliables… La référence en la matière reste certainement l'île de Pâques à 3500 kilomètres des côtes chilienne. Sur cette île, vous trouverez des statues monumentales en pierre, qu'on appelle Moaï, toutes tournées vers l'intérieur de l'Île. Encore aujourd'hui, de nombreuses questions restent sans réponse. On ne connait toujours pas, avec certitude, la symbolique de ces statues dont certaines comportent des messages codés que personne n'a encore n'a réussi à déchiffrer. Il semblerait qu'elle représente des chefs ou encore des divinités, mais encore une fois, rien n'est sûr. A-t-on d'autres destinations dans la même veine ? Est-ce qu'il y a des lieux mystérieux qu'on ne peut pas visiter ? Écoutez la suite de cet épisode de "Maintenant vous savez". Un podcast Bababam Originals, écrit et réalisé par Joanne Bourdin. À écouter aussi : ⁠Comment vaincre sa peur de l'eau ?⁠ ⁠Qu'est-ce que le "quiet vacationing", cette pratique controversée ?⁠ ⁠Qu'est-ce que le R-Bombing, cette tendance amoureuse toxique ?⁠ Retrouvez tous les épisodes de "Maintenant vous savez". Suivez Bababam sur Instagram. première diffusion le 14/08/2024 Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we're pulling back the curtain on a long-standing myth in the American hunting community: that 1 MOA equals 1 inch at 100 yards. Spoiler alert—it doesn't. Jamie Dodson walks you through the real math behind minutes and mils, compares their pros and cons, and explains why the “language of hunters” might be more marketing than fact. We're diving deep into how rounding MOA values distorts your accuracy, why mils are faster, cleaner, and more honest, and why most of the world—and long-range shooters—prefer them. If you've ever been told that minutes are "simple" or "easier," this episode might change the way you shoot forever. Plus, we preview next week's episode where we expose the truth behind BDC turrets—it's not bullet drop compensation, it's being duped for cash. Brought to you by: Krieger Barrels: Cut-rifled, American-made precision barrels. MDT: Makers of elite competition and hunting rifle chassis. TriggerTech: Precision triggers we trust—and actually use. Heads up: 2026 Long-Range Shooting School dates go live August 1st—with early bird discounts and limited slots!

The guys discuss age on this one. Brandon is turning 44 which was the number we thought was worn by full back Mike Alstott(turns out he's number 40). Credere weaves a metaphor of his on field prowess to how we should live day to day. The battle of the LA zoo. Watching Carlitos Way again, really hits different. Red Bull light, daily recommended dose of caffeine and Jager bombs end up in Energy Drink Round-Up. Fuck having long hair and bicycles. Brandon's mom confirms how many of his ticks/quirks are actually just hand me downs. The Moa is being brought back, why?

The famous modder behind the Special K mod has deleted their steam account and written a manifesto about why Steam is evil. We disagree.The resurrected Direwolves are doing well, and Peter Jackson is promising to bring back the Moa next. Let's just skip straight to the dinosaurs.Movies used to be based on comics. But now movies are bigger than comics, and people think comics are worse for it.We enjoyed a nice drink of rez which you can get a 10% discount when you type NERDS at the checkout from the Rez website at www.drinkrez.com Modders Deleting their Steam out of protest- Why I Deleted My Steam Account After 20 Years · GitHub Direwolf Update & Peter Jackson's Newest Project- The "de-extincted" dire wolves are 6 months old and getting quite big - Peter Jackson, Maoris, Colossal To De-Extinct World's Largest Bird Have Superhero movies ruined Comics- Have Superhero Movies Ruined Comics? - ComicBook.com Stop Killing Games Petition : https://www.stopkillinggames.com/Full Show notes : https://docs.google.com/document/d/1GLMqvP51TVY5wFL_4B5RUx04eNV_uv7uSGeRl3zjtyw/edit?usp=sharing Follow us onDiscord - https://discord.gg/VqdBVH5aFacebook Page - https://www.facebook.com/NerdsAmalgamated/Twitter - https://twitter.com/NAmalgamatedInstagram - https://www.instagram.com/nerds_amalgamated/Youtube - https://www.youtube.com/@nerdsamalgamatedTikTok - https://www.tiktok.com/@nerdsamalgamatedTwitch - https://www.twitch.tv/nerdsamalgamated Hosted on Acast. See acast.com/privacy for more information.

Moa Gustafsson bärgade nyligen ett EM-silver i Body Fitness i Spanien. Vi snackar om det, men även om vägen dit, om hennes kärlek till crossfit, och om hennes förberedelser inför höstens VM. Moa om EM-silvret: 00:06:55 – Moa in 00:59:41 – Moa ut Mer från Tyngre Radio Avslutningsvis – du som lyssnar på vår podcast får gärna betygsätta den på Apple Podcasts – lämna gärna en recension. Då blir podden mer synlig för andra plus att värdarna blir glada.

Moa har fasat och beklagat sig men det kommer att ske, att hon i sommar fyller 30 år. Som present överraskar vi henne med ett hyllningsprogram fullt med skratt och politik. Men Moa tycker inte om överraskningar och är nära att lämna studion. Lyssna på alla avsnitt i Sveriges Radio Play. Producent: Sukran KavakDigital redaktör: Linna FogelbergProgrammet spelades in fredagen den 30 juni 2025

• Pinball Dudes ad promoting pinball machine sales, rentals, and delivery in Florida • Discussion of various pinball machine types from different decades • Deadpool pinball machine currently in Tom & Dan's studio lobby • Renting pinball machines as office decor and entertainment • Praise for Andrew from Pinball Dudes and his customer service • Dan jokes that pinball machines make businesses seem more successful • Ross McCoy joins the show as a guest • Ross holds the Deadpool pinball record at the studio • Ross McCoy plugs his podcast, The Orlando Talk Show, with producer Logan • Promotion of the Just Call Moe Family Skate-A-Thon at Cimarron Skateway • Tom plans to bring his daughter and her friend to the skate-a-thon • Cimarron Skateway described as a time capsule of the '80s • Expectation that event attendees should show up if they RSVP • Frustration with people who RSVP but don't show up • Event organizers expecting large no-show numbers despite RSVPs • Prediction that 40-60% of RSVPs won't attend the skating event • Discussion of how some people live disorganized, flakey lifestyles • Dan expresses disbelief that so many people flake after registering • Segment on conspiracy theories surrounding Gary Coleman's death • Recap of Gary Coleman's fall down the stairs and the mystery surrounding it • History of domestic violence between Gary Coleman and his ex-wife • Gary Coleman worked as a security guard later in life • Story from Molly Shannon about Gary Coleman making inappropriate advances toward her • Ross reacts to live lie detector results from Gary Coleman's ex-wife • Gary Coleman was conscious after the fall and reportedly said he fell • Host jokes about lie detector guy being confident without directly saying she killed Gary Coleman • 911 call from Gary Coleman's ex-wife sounded emotionless and suspicious • Jokes about Gary Coleman's different strokes bike shop molestation episode • Frustration that Gary Coleman isn't remembered fondly by anyone except Todd Bridges • Introduction of Finnish wife-carrying competition topic • Explanation of historical origins of wife-carrying involving bandit Herco Ronkainen • Herco used grain-carrying trials to form his group of outlaws • Wife-carrying competition now includes standardized positions and events • Joke that Gary was “testing” Molly for a wife-carrying contest • Ross brings up the Skinwalker Ranch show and billionaire owner Brandon Fugal • Mention that Brandon Fugal's company is working on cloning extinct creatures • Fugal's company recently announced plans to clone a Moa bird • Peter Jackson owns one of the largest Moa artifact collections • Hosts express excitement over seeing a Moa but acknowledge ethical issues • Dan jokes about riding a Moa like a Tauntaun from Star Wars • Commentary that Brandon Fugal may be closest to building a real Jurassic Park • Ross recently finished working fireworks season • Mention of watching the final season of Squid Game • Dan unsure how many seasons of Squid Game there are, suggesting show lost popularity • Conversation about hair growth speed differences • Dan discusses his penis retraction issues due to aging and surgery • Dan makes jokes about foreskin and anti-circumcision stance • Reminder to register online and sign waiver for skating event • Andrea already signed Dan up for the skating waiver • Skating rink system recognizes regulars for auto waiver sign-in • Discussion on flakiness and reliability of guests • Reference to Facebook Marketplace behavior and user frustrations • Common annoyance with “Is this still available?” auto-messages • Ross admits to hoarding Mac computers and struggling to let go • Problems with buyers not reading full listings before messaging • Many buyers ask questions already answered in the item description • Some people offer half the listed price immediately • Criticism of how little effort people put in before bailing • Comparison to Planet Fitness and how businesses profit off non-commitment ### **Social Media:**   [Website](https://tomanddan.com/) | [Twitter](https://twitter.com/tomanddanlive) | [Facebook](https://facebook.com/amediocretime) | [Instagram](https://instagram.com/tomanddanlive) **Where to Find the Show:**   [Apple Podcasts](https://podcasts.apple.com/us/podcast/a-mediocre-time/id334142682) | [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2FtZWRpb2NyZXRpbWUvcG9kY2FzdC54bWw) | [TuneIn](https://tunein.com/podcasts/Comedy/A-Mediocre-Time-p364156/) **The Tom & Dan Radio Show on Real Radio 104.1:**   [Apple Podcasts](https://podcasts.apple.com/us/podcast/a-corporate-time/id975258990) | [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2Fjb3Jwb3JhdGV0aW1lL3BvZGNhc3QueG1s) | [TuneIn](https://tunein.com/podcasts/Comedy/A-Corporate-Time-p1038501/) **Exclusive Content:** [Join BDM](https://tomanddan.com/registration) **Merch:** [Shop Tom & Dan](https://tomanddan.myshopify.com/)

Slurpee Day and Measles… Rainmaker claims it wasn't him… Death toll rises from Texas floods… www.mercuryone.org Low-Orbit Space chip and drug making… AI taking over… Email: ChewingTheFat@theblaze.com Netflix free acct scam… The Band Oasis upping security… Matcha shortage… at Guy Seating on rides and planes… Who Died Today: Dr. Ronald Moy 68… Akon's Real Life Wakenda in Senegal scrapped… Colossal bringing back The Moa?... Neanderthal Fat Factory… Joke of The Day… Game Show: What's The Lie? Contestant: Mark Higginson…www.blazetv.com/jeffyPromo code Jeffy… Learn more about your ad choices. Visit megaphone.fm/adchoices

Buenos días, soy Yoani Sánchez y en el "cafecito informativo" de este jueves 10 de julio de 2025 tocaré estos temas: - Moa, la ciudad cubana que se asfixia - México se consagra como el nuevo mecenas petrolero de La Habana - Los cubanos gastan más en las pymes que en las empresas estatales - Homenaje a Juan Gualberto Gómez en Madrid Gracias por compartir este "cafecito informativo" y te espero para el programa de mañana. Puedes conocer más detalles de estas noticias en el diario https://www.14ymedio.com Los enlaces de hoy, para abrirlos desde la Isla se debe usar un proxy o un VPN para evadir la censura: El Gobierno minimiza la grave contaminación por polvo tóxico de la planta de níquel en Moa https://www.14ymedio.com/cuba/gobierno-minimiza-grave-contaminacion-polvo_1_1115732.html En el Sistema de Nacional de Salud, el que no paga, espera o se muere Pemex envió petróleo a Cuba por valor de 166 millones de dólares en el primer trimestre de 2025 https://www.14ymedio.com/internacional/pemex-envio-petroleo-cuba-166_1_1115721.html Los cubanos gastaron más dinero en las pymes que en las empresas estatales en 2024 https://www.14ymedio.com/economia/cubanos-gastaron-dinero-pymes-empresas_1_1115723.html Mientras protege a criminales, La Habana actualiza su lista de "terroristas", que incluye a 'influencers' https://www.14ymedio.com/cuba/protege-criminales-habana-actualiza-lista_1_1115734.html Quiero ser chofer de Foton, la nueva guagüita china con aire acondicionado https://www.14ymedio.com/cuba/quiero-chofer-foton-nueva-guagueita_1_1115722.html Pasar calor o estar fresco, el dólar marca la diferencia en Carlos III https://www.14ymedio.com/cuba/pasar-calor-fresco-dolar-marca_1_1115726.html Tras la muerte de un preso en huelga de hambre, Cubalex advierte del riesgo para la vida de otros dos https://www.14ymedio.com/cuba/muerte-preso-huelga-hambre-cubalex_1_1115710.html Ante la falta de peloteros para el Clásico, Cuba debate invitar a los que ‘desertaron' https://www.14ymedio.com/deportes/falta-peloteros-clasico-mundial-cuba_1_1115730.html Clausura del 170 aniversario de Juan Gualberto Gómez https://www.14ymedio.com/cartelera/clausura-170-aniversario-juan-gualberto_1_1115745.html

With Mike Hosking off on holiday, Heather du Plessis-Allan was joined by Tim Wilson and Trish Sherson to Wrap the Week that was. They discussed the situation with the gold mine, lizards, and Department of Conservation, the company working to resurrect the moa, and ask the question of if it's better to be smart or dumb. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Moa Rivera (Gerardo Rivera Donis), lleva la salsa de su Puerto Rico natal en las venas, y está impulsando una renovación de la salsa, combinando su tradición con toques modernos dentro del género.Moa se consolida como figura destacada en la industria quien a los 16 años compuso su primer tema.Un artista disciplinado en artes marciales, estudió cine y artes culinarias.Con su más reciente sencillo “No Quiero Extrañarte” en El Poder de la Música, su historia.https://www.instagram.com/moa.pr/https://www.instagram.com/humbertoelgato/

On today's show, how will the big beautiful bill affect venture capital? We have more job movement news, people getting hired, people leaving companies. And the Moa bird, that's been extinct for hundreds of years, is being brough back to life.

Dans cet extrait, Laetitia raconte les moments les plus compliqués de leur voyage. Lisa s'est cassé les deux bras, une situation difficile à gérer seule avec deux enfants. Avant de partir, Laetitia avait inventé un code secret à utiliser si ses filles se sentaient en danger. Elles l'ont testé une première fois dans une piscine. Et à Rio, avant de monter dans un taxi, elle note le numéro du véhicule — “au cas où” — une manière de les rassurer, et de rester en alerte.Lisa se casse les deux bras pendant le voyageun code secret imaginé pour communiquer en cas de dangerun test en piscine, pour que ce soit concretprécaution prise à Rio en notant le numéro du taxiÀ écouter pour découvrir comment Laetitia a géré les galères, sans céder à la panique, avec calme et créativité.

Today on the radio show. 1 - Smoko chat. Justin Loomans. 7 - Bringing back the Moa. 10 - Origin - Who are you supporting? 13 - Bloke makes a travelling bed. https://shorturl.at/fut9f 17 - How long have you spent in bed? 22 - Oasis Fashion. 25 - Origin moments that matter. 28 - Iron Maiden Coin. 31 - Late mail. 36 - Last drinks. Get in touch with us: https://linktr.ee/therockdrive

A Otago University professor says extinction is forever and the moa isn't coming back. A US genetic engineering project with backing from Peter Jackson claims it might restore the extinct South Island moa to New Zealand within a decade. But zoology professor Philip Seddon says he's questioning the researchers' goal and whether it's even possible. "Its genetics will be different, its physiology will be different, its behaviour will be different. There's a lot of question marks about whether a GMO version of a moa is actually going to be useful at all." LISTEN ABOVESee omnystudio.com/listener for privacy information.

The moa was a visionary bird well ahead of its time. Bringing them back from extinction makes perfect sense - we'll be setting them free. They can finally live their best life. Spread their wings - metaphorically, of course, cause they don't actually have wings. But they'll be free in this brave, new modern world. Firstly, they're vegan. So hip and trendy box number one - big tick. Wait till somebody introduces them to the incredible burger, or eggplant sandwiches with vegan slaw. They'll love that. But wait, it gets woker. The women are dominant - one and half times bigger than the men and two and half times the weight. Trendy, progressive box number two - tick. Number 3 - turns out they were quite oppressed back in the day. Victims, you could call them. Also very trendy today. Hunted to extinction by men with spears, slaughtered and eaten. You know what that means in 2025 - lived experience. Wait for the wellness podcast and the Oprah interview. And then there's the obvious but awkward issue of being a bird with no wings. A bird that can't fly. Kiwi are so embarrassed by this they only come out at night in case any one notices this deformity. But moa stand at up to 3.5m tall in broad daylight, which is quite hard to miss. It's not like you can hide behind another bird or a tree or anything else, really. They stick out like the Sky Tower, which is more fodder for the podcast, no doubt. So to the moa, who we will soon raise from the dead: Welcome to a brand new world. Welcome the world you deserved from the beginning. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Today G-Lane, Manaia and Mash discussed things that your children do that you're not meant to be proud of, but you secretely are. Plus Peter Jackson is trying to bring back the Moa...See omnystudio.com/listener for privacy information.

In today's episode, Sir Peter Jackson is backing an ambitious project effort to bring back the Moa from extinction, and it is being led Ngāi Tahu, Canterbury Museum, and Colossal Biosciences; Health New Zealand has backed down on plans to give Wellington Hospital maternity beds to ED patients; over 15 years, more than 900 Post Office branch managers were wrongly prosecuted for theft and false accounting, because of the faulty Horizon IT software they were required to use; US President Donald Trump has doubled down on his new tariff deadline of August 1st, posting on social media that "there will be no change" to the date, and "no extensions will be granted"; why are so many Kiwis interested in a state-based Australian rugby league series?; and the Cardrona Hotel is proving to be hot property - if its Trade Me views are anything to go by.

Sir Peter Jackson is backing an ambitious project effort to bring back the Moa from extinction, and it is being led by Ngāi Tahu, Canterbury Museum, and Colossal Biosciences. Chief executive and co-founder Ben Lamm spoke to Ingrid Hipkiss.

Budget, logement, transport, visites, météo… Laetitia partage tout ce qu'il faut savoir pour organiser un voyage en famille à l'île de Pâques.Dans cet extrait, elle détaille les choix qui ont facilité son séjour avec deux enfants, et les astuces pour éviter les pièges d'un lieu aussi isolé.comment trouver des billets à prix correctoù loger et pourquoi choisir une cuisineorganiser les visites avec une guide francophonece qu'il faut prévoir (météo, alimentation, transport)Un guide pratique à écouter avant de réserver ses billets pour Rapa Nui.

There's a belief a plan to resurrect the extinct Moa will have ample roll-on effects. US company Colossal Bioscience has partnered with Ngāi Tahu in a $50 million project to revive the flightless bird through gene editing. Canterbury Museum's Senior Curator of Natural History Paul Scofield says it's a great eco-tourism opportunity. He told Heather du Plessis-Allan people could come and see Moa roaming the hills in a reserve. Scofield says scientists would also be able to see how these birds affected the ecology of New Zealand. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Det finns ett sommarprogram som Lova och Moa garanterat kommer att lyssna på. I år sommarpratar talmannen Andreas Norlén. Han talar om hopp och historia, dikter och demokrati, tomater och talmansrundor och kanske en del annat.Lyssna på Sommar i P1 exklusivt i Sveriges Radio Play

Une semaine à l'île de Pâques, ce n'est pas que des statues. C'est aussi une organisation simple : école le matin, balades l'après-midi, coucher de soleil au même endroit chaque soir. Dans cet extrait, Laetitia raconte la mise en place de leur rythme, entre apprentissage, visites guidées avec Keka, pique-nique orageux, et légendes partagées.l'école avec les carnets de voyageles visites guidées avec Keka, guide locale francophonele rituel du coucher de soleilles moments imprévus devenus souvenirsUn épisode qui montre comment la routine, en voyage, peut devenir un ancrage joyeux.

Laetitia raconte leur arrivée à Rapa Nui, une île perdue dans le Pacifique où l'accueil commence avec des colliers de fleurs et se poursuit avec un hébergement… face à un Moaï.Dans cet extrait, elle partage le choc de la découverte, la beauté brute du lieu et le début de cette parenthèse hors du temps.arrivée sur l'île avec LATAM et accueil traditionnelpremier jour d'émerveillement face aux statuesinstallation dans un logement tout équipé avec vue directe sur les Moaïsimpression d'être déjà dans un autre rythme

Welcome to Episode 238 of Wolf Precision's Long Range Shooting and Custom Rifle Building Podcast! In this first installment of our new series, we dive deep into one of the most frustrating questions in precision shooting: Why isn't my rifle shooting accurately? Drawing on two decades of experience at the firing line, Jamie breaks down the foundational issues that plague both factory and custom rifles—starting with your components, your scope setup, the torque on your action screws, and the hidden dangers of poor manufacturing tolerances. Whether it's a misaligned base, budget stock flex, or a bad muzzle brake thread job, we cover it all. Also in this episode: The truth behind MOA claims from rifle manufacturers Why we use TriggerTech and Krieger Barrels exclusively Tips on how to test your suppressor alignment and protect your gear Behind-the-scenes at Wolf Precision and what we do to help shooters succeed If you're serious about improving your shooting or just want to avoid common pitfalls, this is a must-listen.

Double Tap Episode 416 This episode of Double Tap is brought to you by: Gideon Optics, XTech Tactical, Die Free Co., Medical Gear Outfitters, Mitchell Defense, and Blue Alpha   Welcome to Double Tap, episode 416! Your hosts tonight are Jeremy Pozderac, Aaron Krieger, Nick Lynch, and me Shawn Herrin, welcome to the show! GOALS   August 9th and 10th in Knoxville, Tennessee. Knoxville Convention Center Free to GOA members https://events.goa.org/goals/ - Dear WLS A-in-your-face. WLS is life - Long story short, I had a medical event while on vacation in Mexico and the care there sucked! (I do not recommend) A med kit wouldn't have helped my situation much but it got me thinking. In the states when I travel via vehicle, I always have at least one pretty stocked med kit on me. But I have never thought to take a minimum of supplies when I fly on vacation or when I travel to other countries. What things would you recommend in a travel kit, at a minimum? Thinking that you dont have your vehicle, might be in another country, and may have restrictions on the things you bring? I am thinking a small minimum kit of a couple essentials would be smart... #no_notes Sean M - Suppressor Mount Question, I'm putting together a BRN180 with an 10.5" 5.56 barrel and have a Griffin GP7 ready to go. Being that it will need a thread adapter (from 1/2-28 to 5/8-24) would it be better to pin and weld or silver solder that setup?   A-ARONS lost foot - I recently bought my first lever action gun and I don't know to go Red Dot route or if I should go lpbo route. I bought a Marlin 1895 BL and 4570 and in terms of use case, it's going to be arranged toy. Could be used for hunting for the down the road, but possibility is open. with the cast do a red dot or lpvo and just thoughts of why they went with that decision if they were me? Thanks my dudes Alex W - I've been listening to this podcast every week for 5 years. How the fuck did I not know that Shawn and Jeremy play DnD??   Dane G - Hello wls. First off love the show guys. Looking at starting a home ffl. Was thinking of using rocketffl to get started. I think Shawn used them to get started and was wondering the process of it. I know you use an office space, would you recommend that so my home address isn't public? Feel like that's putting a huge target on my home. Thanks guys. Ps. If I was gay I'd suck your titties Shawn. Dutch Walker - My Mitchell Defense story. Roughly a year ago, I picked up a Mitchell Defense rifle in 6 ARC. I was excited when they started offering this caliber, especially after hearing high praise from Shawn and Nick. An interview with Nathan Mitchell, the company's founder, sealed the deal, and I ordered one right away.First Impressions out of the box, the rifle looked fantastic, the components were of high quality and I was eager to take it to the range.The rifle ran smoothly, cycling perfectly with or without a suppressor. But when I tested its accuracy my groups at 100 yards were consistently over 3 inches, no matter the ammo. To make sure it wasn't me, I shot other ARs, including another in 6 ARC, and got sub-MOA groups. I contacted Mitchell Defense, and Nathan himself called me to talk through the issue. He immediately sent an RMA for the upper. His team wasn't satisfied with its performance either, so they upgraded me to a Proof carbon fiber barrel at no extra cost—a serious step up. Unfortunately, the new barrel had the same problem. I'd get three shots grouped tightly, but two would stray 2-3 inches in random directions. I sent Nathan photos of my groups, and he replied with some troubleshooting tips. Sometime later, when I emailed him to let him know I was heading to the range to try his suggestions, he called again. This time, he said they'd found an issue with certain Proof barrels and sent another RMA. A few weeks ago, I got my rifle back with a new Proof barrel. Last weekend, despite 17-20 mph crosswinds,

Durrell Smith, native of Atlanta, Georgia, is the creator of the The Sporting Life Notebook and cofounder of Minority Outdoor Alliance. You can follow Durrell and learn about MOA events via Instagram: @minorityoutdooralliance @thesportinglifenotebook   - - - - - - - - - - - - - - - - - - - - For a 15% discount on SKRE Gear, use code NYC - - - - - - - - - - - - - - - - - - - - Follow Cliff and Devian on Instagram Cliff: @urbanarcherynyc Devian: @citykidbushcraft  

Lova gissar rätt på Liberalernas nya partiledare, Simona Mohamsson och Moa är inte förvånad att Romina Pourmokhtari sa nej. Lova har varit i vildarnas korridor där en startat nytt parti och David skäms när Katherine sjunger för första gången i radio. Lyssna på alla avsnitt i Sveriges Radio Play. Producent: Sukran KavakDigital redaktör: Linna FogelbergProgrammet spelades in den 18 juni 2025

Innovation in medicine is happening. In our immediate past episode, we summarized how AI is improving standard mammography to now PREDICT breast cancer rather than just diagnosing it once it was appeared. In a past episode, we covered a new and novel “first in class” oral medication for uncomplicated UTIs in women called Blujepa. This is innovation! Well now, as of June 10, 2025, the FDA has granted a New Drud Application for a new and noval oral antibiotic against gonococcal (GC) infection! In this episode, we will review the current CDC treatment protocols for GC and highlight what this new medication's MOA is and what to expect from this FDA process.

Which is more accurate—a precision bolt action or a well-built AR-15? In this video, we dive deep into the long-standing debate between traditional bolt rifles and modern AR platforms. Wade puts both to the test, breaking down the myths, the mechanics, and real-world results that matter to hunters, shooters, and everyday riflemen.We'll cover:Key differences in design and performanceHow barrel quality, ammo, and optics change the gameReal-world shooting comparisonsWhen each rifle type shinesWhether you're chasing sub-MOA groups or just love good rifle talk, this one's for you.

On today's episode of The Wholesome Fertility Podcast, I'm joined by Jiaming Ju @kunhealth, a second-generation traditional Chinese medicine (TCM) practitioner and health economist who co-founded Kun Health with her father. From leading one of the world's largest longevity data projects to creating personalised Chinese herbal formulations, Jiaming brings a rare and fascinating perspective to holistic fertility care. We dive deep into the roots of Chinese medicine and its powerful role in treating unexplained infertility, recurrent miscarriage, and postpartum recovery. Jiaming shares why customized herbal medicine—rather than a one-size-fits-all approach—is key, and how stress, liver qi stagnation, and over-medicalisation can often stand in the way of conception. We also discuss the importance of preparing the body and mind for pregnancy, how men's health is often overlooked in fertility journeys, and the practice of wu wei—doing nothing—as a healing principle. This is an eye-opening and empowering conversation for anyone navigating fertility or seeking a deeper understanding of the interconnectedness of health, mindset, and tradition. Key Takeaways:  Chinese herbal medicine offers a deeply personalized and effective approach to treating fertility challenges, especially unexplained infertility and miscarriage. Liver qi stagnation and chronic stress are common root causes in fertility struggles. True healing goes beyond quick fixes—it involves preparing the whole body and mind for pregnancy, not just aiming for a positive test. Partner health, especially sperm quality, is often under-acknowledged and under-tested in fertility journeys. Practicing wu wei—intentional rest and non-productivity—can help calm the nervous system and enhance reproductive health. Guest Bio: Jiaming Ju is the co-founder of KUN Health, where she partners with her father to offer personalised Traditional Chinese Medicine (TCM) care rooted in decades of lineage and wisdom. Before stepping into the world of herbal medicine, Jiaming led one of the largest global data projects on aging, spanning from New York to Singapore. With a background in health economics and longevity research, she brings a unique perspective to healing—bridging ancient Chinese traditions with modern insights. Together with her father, she helps individuals restore balance, improve fertility, and honour the heritage of Chinese medicine through customised herbal formulations and deep one-on-one care. Websites/Social Media Links: Learn more about KUN Health hereFollow Jiaming Ju in Instagram —------------- For more information about Michelle, visit www.michelleoravitz.com To learn more about ancient wisdom and fertility, you can get Michelle's book at: https://www.michelleoravitz.com/thewayoffertility The Wholesome Fertility facebook group is where you can find free resources and support: https://www.facebook.com/groups/2149554308396504/ Instagram: @thewholesomelotusfertility Facebook: https://www.facebook.com/thewholesomelotus/ _____ Transcript: **Michelle Oravitz:** [00:00:00] Welcome to the podcast Jiaming.  **Jiaming Ju:** Thank you for having me.  **Michelle Oravitz:** Yes. I would love for you to share your background. I know you're second generation, um, traditional Chinese medicine practitioner, which is really cool. Um, I love the fact that you actually have your roots there and your father does too, and I feel like. That kind of takes it to a whole other level when you're working and learning from your parents. So I'd love to hear your background and have you share it with the listeners. **Jiaming Ju:** Uh, so I'm a health economist first. So I was in health, I was in economics basically for 10 years. Um, and. I think before Covid I was running one of the largest think tank on longevity, uh, data collecting in the world at the time in Singapore. Um, and then I came back to the States in 2019 and decided to [00:01:00] retrain for four years. It takes four years in California. And then, um, that's when also around the same time I opened Quinn.  **Michelle Oravitz:** Awesome. So, um, do you Longevity? I think of longevity and I think about fertility. 'cause a lot of times when we treat fertility, we're actually doing a lot of anti-aging. Um, we don't call it that 'cause we're working on mitochondria and really kind of getting the health, um, of the eggs and the uterine lining. So tell us about your experience with fertility and what you've, um, what you've seen. In practice. **Jiaming Ju:** Well, I mean, I work with a lot of people who have unexplained infertility. That's actually an area that, um, that I work a lot in. And, uh, this applies to both men and women among my patients. So I will have. A lot of patients who, uh, you know, they probably had a failed, failed rounds of IVF. [00:02:00] Um, and then that's when we work together. I also have a lot of patients, um, who have repetitive miscarriage, uh, which is increasingly, uh, common, unfortunately. And then I also work with a lot of women on postpartum, which is more on the traditional side, as you know, in Chinese medicine.  **Michelle Oravitz:** Yes, and so I know that we often get asked this, and I get asked this too, but I love always hearing the different perspectives on Chinese medicine. To explain to people in layman terms, why does acupuncture and Chinese medicine, I know Chinese medicine's a big umbrella. Acupuncture is really one part. I think most people think just acupuncture, but of course there's MOA herbs. I mean, there's so many different things. There's also auricular, you can get really detailed on that. So can you explain what Chinese medicine could do really to regulate periods, to regulate ovulation? Just kind of help fertility.[00:03:00]  **Jiaming Ju:** Well, I mean, first off, I think I grew up in the Chinese medicine family business, so to me it's very bizarre when people separate them. Um, you  **Michelle Oravitz:** the acupuncture and the herbs and the, **Jiaming Ju:** treatment from the, herbal treatment. However, I think, um, customized herbal formulation has always been the elitist form of Chinese medicine. It takes a lot of family lineage. Um, you know, pre bottled stuff aside for the modern human really, you know, whether you have fertility issues or not is really that one has to take a one-on-one approach to effectively treat something that's very complex. So having said that, um, I only work at Quinn for customized herbal formulation, so we don't do, although I'm licensed, I don't do acupuncture, uh,  **Michelle Oravitz:** Oh, got it. Oh, I didn't know that. I thought you did acupuncture as  **Jiaming Ju:** no I don't.  **Michelle Oravitz:** Oh, okay.  **Jiaming Ju:** We have all of you guys who are.  **Michelle Oravitz:** actually, um, I know in China they do separate it. A lot of times people will get really, really [00:04:00] focused on one aspect.  **Jiaming Ju:** Um, yes and no. I think in if, because in China and Korea they have TCM hospitals, right? So you have different departments where post-stroke, you go first off to the acupuncture people, which is the physical therapy part of Chinese medicine. And then. Depending on the severity of the stroke, you likely will get customized herbal formulation on top of that. Um, I usually say that, um, acupuncture is amazing, is like a great deep spring cl that everyone needs it often, um, customized herbal formulation and diagnosis is more like a renovation, so they're entirely different projects. I think when you consider a human as a house, right, you're building a house, you need, you have different needs. Um, in terms of female, I think we go back to the topic. I always like to talk about how, uh, women are fundamentally very, very important in Chinese medicine [00:05:00] because Chinese historically are obsessed with babies. Um, so this is the reason why a long time ago in all these empress, like, you know, like palaces, you will have. Uh, a whole college of hundreds of royal physicians, and they're all Chinese medicine doctors. And their goals are not only to keep, to make sure the emperor can live for as long as possible, is to make sure all these concubines can produce as many kids as possible. So this is why I think the, the practice, um, has a lot more interest in the history, right? The history is being that. We love kids and you want, China has one of the largest population in the world throughout history and you know, so it has a lot of that. You want kids and you need to care about women's health. So in a nutshell, I really like what you mentioned before, like when I actively worked as a, basically a longevity economist and my job was to advise countries in terms of, um, you know, fertility policies, aging population, right? How can you encourage, [00:06:00] and I often say that women's. Women friendly policies are essentially longevity policies. You don't have women giving birth to kids, then you won't have a, you know, sustainable population. This is one of the same. So I really liked you pointed that out. That is totally right. I think not many people think like that. Um. And so in a nutshell, like there is the historical interest then that would mean that in terms of research, there is the interest in the research, there is interest in data, there is, uh, Chinese medicine has been around for 3000 years and gynecology in particular in that field has been around for 3000 years. This is very different with how western medicine has developed. Right? Like c-section technique for example, was developed, I dunno, a hundred years ago, like it is very. It's, it is, it is. So it's really like not comparable in terms of history, even sheer patient number and uh, patient cases. So I think Chinese medicine really in many ways excel in understanding women's health [00:07:00] and fertility. I.  **Michelle Oravitz:** For sure. And I, I always say like with medicine, one of the key things that you wanna look at is how well does it age And Chinese medicine ages really well. So a lot of times you'll see new things, new pharmaceuticals, and then a couple years later you find out it's not as great and then something else comes out with Chinese medicine. I mean, it looks at nature, it really looks at like the elements of nature. That is something that is consistent. It's just part of really understanding that and then understanding ourselves. So I think that that is so cool about Chinese medicine. **Jiaming Ju:** Right. The internal is very much so the physical, right. I have, I'm sure you have too, a lot of patients who on the surface they're like. Really healthy. Uh, but they haven't had a period for three years. So, you know, this is, this is not, and then they will spend the money on Botox. But which then you're like, okay, you look good for maybe a [00:08:00] month, and then you have to do this again. Right. It, it is very different perspective. I think, um, many people say that, you know, why do, for example, in the practice of, uh, postpartum recovery, right? I'm sure you see it, and I see it a lot from the practice where. People who don't have, who are not on top of their health condition, especially in terms of digestive health. I'm more prone to have thyroid issues or, you know, uh, preeclampsia in the last trimester and then post burst. This doesn't only drag their health just downhill. And then also impact how you're going to have a second kid or a third kid if you want to. It really completely like, you know. Like it really completely wrecks your house in a ways that you didn't even see this coming. And that is a completely different perspective, right? Because often I will have patients who say that, oh, you are the first person who listens. How do you know I have these issues? Before I even tell you, I. It is really patterns. And I go back because [00:09:00] I am a nerd and I am an economist. Like I go back to data collecting Chinese medicine like in my father's, you know, practice. Like he will start seeing a kid at the age from the age of five and then she's, he sees the same kid when the kid is 35. You see a person's in a whole families right Conditions throughout their whole life, and That's The best possible data collection you can dream of, and you can think of. This is not just a, oh, here is some pills for antidepressant, for postpartum depression. Like give a women a pill like that. They will still have gazillion other issues, like what does this solve? And you will hear often for people who have postpartum depression, for example, right? Like they will then be dependent on depre antidepressant for the rest of their life. Then one questions. What does that serve? Right? Where does that put you as a human? Do you feel like you are out of control for your own health? Um, so Yeah. it's a different approach.  **Michelle Oravitz:** Yeah, completely. Uh, it's interesting you say about [00:10:00] antidepressants because I feel like it's almost, um, a screen in between me and the person. I feel like I'm not able to fully get through to the person with the treatments because there's something in the middle, in the way I. And um, and of course I don't tell them just stop because I know that that is a whole process. They have to be under the care of a doctor and tell them how to come out of it, because it's not something that you can just suddenly take out. I often feel like that. And I'd much rather if I can just treat it with nothing else, it'll be a lot easier. And then another thing too is um, that I thought you said that was really interesting and true is, um, you know, I think a lot of times often people just want that positive pregnancy, but you talked about something that is actually crucial. If people want a healthy pregnancy and then also healthy afterwards for more kids, you really have to think big picture and not just quick fix. And I [00:11:00] think that we're so conditioned for the quick fix that we don't think about the whole garden and really tending the soil. And I always think about it like that. It's like, yeah, we could throw a seed in and maybe that's gonna sprout. But if we don't give it the conditions it needs, those roots aren't gonna go deep and it's not gonna be a sustainable, like rooted sprout, which I think similar with pregnancy, you want not just pregnancy, but you want a healthy pregnancy, and you also want a healthy mom and baby. You need it all. It's not like you can have an unhealthy mom, healthy baby. You have to have the whole picture working together. **Jiaming Ju:** I think that's why like many people getting on IVF, and if you consider it a percentage of success rate for IVF is actually not that high. Right? Um, and then everyone is, and a lot of people are disappointed because they feel like I paid all this money and I, I, I got it. Why is it not happening? I think first off is because we're all conditioned to think that pregnancy is such a simple thing, right? You do it and you'll get [00:12:00] pregnant. Uh, the, in Chinese medicine we always say mental is the physical and vice versa. The impact of stress of our day-to-day demand, of being a modern human, whatever, whatever that means, has a huge number in other fertility potential, right? I often says to, I often say to my, uh, patients, um, and I say like, you know, often because. My patients might, in the middle of it, they're, they didn't come to see me For, fertility, but like after they healed from like long covid or something, they're like, I want to have kids. You know? Now I can really think about it and I will usually say that, you know, definitely be careful with like when you wanna get pregnant, because the healthier you are, the fertile you are, the more fertile you are. Often I think in this society where we talk about IVF technology, ever since it has been introduced, it has become a thing where people feel like, oh, so long as I do it right, I will, it will happen. And often people get very disappointed when [00:13:00] it doesn't happen. And I'm sure you see in your practice a a lot in recent, in the past five years, you know the, there is an increasing percentage of people who have to DOIs. IVF like twice or three times and still maybe without success. Right? Um, so I think there is a lot of, um, a lot to be said about looking at fertility, not just as a functionality that you as a woman or you as a human will just somehow have, but it's really about your overall health, right? Like, and I often talk to people who have repetitive miscarriage. I'm like, your digestive health is everything. Who is gonna carry the baby is gonna be you. Now, if you are having, already having like nausea, dry gagging, like five times a day, even when you're not pregnant, your chances of basically having repetitive miscarriage is probably quite high, right? So we have to fix what's, what is the fundamental thing. It is. Not that let's have a kid, because often [00:14:00] I, um, and I very, I talk about this not very often. But I do treat kids, and you often see a lot of kids who have incredible intolerance for food early in age is due to the fact that mother had a very difficult pregnancy.  Um, so this is very much so linked. It's not, like you said, it's not like the mother has to be in perfect house. So you have a chance, the mother and father in perfect house. So you have a chance of this baby being in perfect house often, even if you could get pregnant, if you have a kid who has so many problems, um, in the first two or three years there, basically. Um, you know, there was one time with a patron of mine who, when he came to see me, he was two and a half years old and he was basically deemed a failure to thrive because he couldn't gain weight and he was having leg diarrhea. Often. He was having crazy eczema. And then you find out the mom during [00:15:00] pregnancy and before pregnancy had a lot of issues. So this is all interlinked. Yeah.  **Michelle Oravitz:** it really is. Another thing I see often is people who do IVF and then they go to the doctor and the doctor says, well, you barely have anything. You really need to start immediately. And I always encourage them, spend a little time prote, you know, preparing yourself if they've never, if they haven't come to me and I say, you're much better off waiting a few months. Taking care of yourself, nourishing yourself, then doing IVF, then rushing into it. 'cause we're just looking at numbers and not kind of thinking about the quality and the preparation.  **Jiaming Ju:** Mm-hmm. ' **Michelle Oravitz:** cause in three months, it's not like you're gonna just lose everything. It's gonna just drop off a cliff. I mean, it's gonna be a few more months. You're gonna be in much better position. **Jiaming Ju:** I think that's totally true. I mean, in, in the old country, in East Asia, when you prepare for pregnancy, six months is very standard. That's when your partner quits smoking. They quit drinking, you know, you both eat [00:16:00] healthy. All of those stuff, Right. Um, and in this country we don't, it's almost like nobody necessarily prepare it. Everyone just expect it would just happen until it doesn't happen after a while and suddenly it goes from, oh, I'm really casual about it, to now I'm in a panic. I must do IVF. Right? Um, and. A large, obviously unexplained infertility has a lot to do with, there are multiple root causes. One of the most common ones I have seen is actually intense liver g stagnation, where often a women consider themselves as a failure for not being able to get pregnant. And the more you and I usually be able to tell with a patient when the first, for the first consultation, they'll say, I need to be pregnant by this date. **Michelle Oravitz:** Right. **Jiaming Ju:** You're not a machine, we're not ai. It doesn't work like that. And often, I also, I don't know whether you experienced this in your practice as well, but I [00:17:00] often, uh, I always ask about better the partner, uh, or whoever, is the sperm donor better? They have tested, oftentimes they have not.  **Michelle Oravitz:** Yeah, I agree.  **Jiaming Ju:** has done all the  work then,  **Michelle Oravitz:** I've seen that a lot and and sometimes the doctors don't even mention it.  **Jiaming Ju:** Right. And it is shocking to me because as we all know. through research, uh, I believe it was the newest study done using collective data from Europe, uh, the sperm quality, both in terms of speed and quality per say, is 50% lower than like. 20, 30 years ago, and this is understandable due to drugs, due to not sleeping, due to not taking care of ourselves, Right. Due to stress. So why is it always that we're plowing the field of a women? And I always say this, I said the worst thing would be I'm p plowing your field. And the seed is subpar then. So,  **Michelle Oravitz:** Correct.  **Jiaming Ju:** right? Like, it's so, like, it's So easy. for the man to get checked. [00:18:00] It takes no time at all.  **Michelle Oravitz:** I know. **Jiaming Ju:** So like how is it in this, like, you know. this is almost common sense both in terms of money, in terms of time, get your, get your sperm donor, you know, partner  checked first. Um, it's, uh, It is interesting. **Michelle Oravitz:** It is for sure. And then also, I mean it's, what's interesting is, yeah, you can get checked and everything looks normal and they're like, everything's perfect. But then the DNA might have something off, which. A normal analysis does not cover that. It's a special test that people take after, and usually they won't do that unless there were like miscarriages or there were failures with, um, the embryos to grow. So they'll, they'll then they'll check the sperm. DNA fragmentation. **Jiaming Ju:** It is always a little too late. And interestingly, um, I think even given my own experience, like I have two kids and they were born in different, two different countries, and I. Uh, [00:19:00] the second one who was born in the us I think the, the, even the md, the gynecologist like checkup is very minimum. There was, you know, like if you want like a, a better, clearer picture, you gotta pay more. Like there is like, I think the, the, the standard of what women are provided in this country in terms of like basic, you know, um, like a, a basic kind of gynecological service, um, throughout is very low compared to other countries. Uh, but I mean that also creates a lot of. Tension and anxiety from first time moms. Right. You don't know. And then you show up and then you said you're having some pain and doctor's like, it's okay. And then You know, there  **Michelle Oravitz:** supported because you know, internally something's off. Like, you're like, I know something's off. I'm not crazy, but like, ah, you're fine. It's in your head.  **Jiaming Ju:** right. And I think through and, and I think that's really the fundamental difference between [00:20:00] Chinese medicine and western medicine. Right. Chinese medicine. This is why a lot of people ask me, they're like, you're a Columbia educated economist. You wrote for the Economist magazine, and then you know, you run Nobel Prize winner think tank like, but like Chinese medicine, it must be so different. It's actually not. Health economics is all about getting subjective health data from. The person you interview, that's not so different from what, what we do in Chinese medicine. It's about you being the patient who knows best about your health, right? So if you say you have a pain, you have a pain, I'm, I'm don't live in your body. I don't get to judge you. I think this is also the reason why so many people feel heard. Chinese medicine clinics, um, where they feel like you're just another pregnant person, like time is up, you are leaving. So it's um, it's a very different process. Yeah.  **Michelle Oravitz:** It is such a different process and I actually remember myself the first time I went to an [00:21:00] acupuncturist. This is like kind of what started it all. I was, uh, in a completely different career and I all I could get from every single doctor I went to was the birth control pills. And people hear hearing this, a lot of my listeners already know my story, but it was just basically I had irregular periods and that was the only answer I can get. Never made sense to me on a intuitive sense. I was like, this just doesn't make sense. There's gotta be something. They're like, Nope, that's just your body. The only time you can have normal periods is if you take this. So I went through 12 years of that and the first time I met. My first doctor, Dr. Lee, who's from China, and he actually happened to specialize in gynecology. He sat with me and one of the biggest takeaways, like the biggest impacts that it had, was him listening to me and asking me questions and showing me interest in every part of my life. And I was like, wow, this is crazy. This is so cool. I've never gotten this much attention from anybody [00:22:00] on like, what's going on in my body? **Jiaming Ju:** right.  **Michelle Oravitz:** And then, um, so that was really fascinating. Of course, that did change my period and I was resolved. I, I did the, you know, real raw herbals and the acupuncture. But then also, uh, looking back when I went to school, one of my teachers said, and it kind of like never left my mind that part of the healing, like the therapy starts before a needle goes in. Just by listening and the second you feel heard, that by itself has an impact on your healing. **Jiaming Ju:** Right. The, the physical is mental and that is, um, observed and in every single way we treat patients. I have, I would just say like 90% of my patients not only have like physical ailments, they have a lot of like mental. Concerns as well. Right. Um, and usually as both the, the [00:23:00] mental improved physical improvement and vice versa. And this usually seems very, like, it's like a huge surprise or a big relief to the patients because they're like you. I mean, I, I didn't have to take antidepressant pill for this whole time. Right. Um, it's, I think is, is is, it is a very interesting. Myth we are told, um, and I, I don't mean this as a, as a, something like a, like I'm simply raising this as a question. How is it that we all come in different shape and form, race, color, experience, lifestyle, choices, all of that, and sexes. And then when you say, okay, someone is suppressed, you give everybody exactly the same. The only thing that varies is in the dosage. **Michelle Oravitz:** Yep. **Jiaming Ju:** Isn't that weird?  **Michelle Oravitz:** Mm-hmm.  **Jiaming Ju:** Right? Like it, and if you ask people who are depressed, um, I'll give you an example because I have a lot of A DHD patients, um, [00:24:00] especially, um, and The first thing I always ask when I examine the tongue, um, for A DHD patients is better. You have anemia. And often they do. Um, but as we know in Chinese medicine, even if the lab says you don't have anemia, your tongue can tell me you have anemia. The, the chance of you being anemic and showing a DHD symptoms is very high. So is that actually a DHD or not? Oftentimes is actually not true. A DHD. This is the reason why a lot of women who, uh, thought they have a DHD got on A DHD medication and then they crash when they don't take the medication, right, their energy crash, their focus crash. Then if, I mean, this is really a questions like if you take something, it works. The minute you stop, it doesn't work. Did they ever work? Right. It's almost  **Michelle Oravitz:** it resolve it? It's not resolving, it's not a, a true solution.  **Jiaming Ju:** Right. And then [00:25:00] when we talk about pregnancy, it's a similar process, Right. Is this just we implant a child in your body? Great. I'm glad technology works, but I think if I recall back in the days when, uh, IVF was invented, It was not supposed to be used so widely in today's environment. It was for, I believe, for specific reason, Right. There was a, a really strong infertility, I believe structurally for. Was it the researcher? We invented it. So like it was not supposed to be. It's the same thing with C-section. It was not supposed to be widely used. Like today's, I remember when I lived in Singapore, uh, C-section was so popular. It was like, you can pick your date. It was a thing you can pick, pick a auspicious date to give birth to your child, and everyone goes to have a csection on the same day. It wasn't designed like that. It wasn't meant to be used like that. So I think. Modern human need of getting things done. [00:26:00] Like I need to have a child. Here is the child, and here the child is delivered like this need of doing, boom, boom, boom. Just click on your life. To-do list is preventing us to see the garden you talked about is preventing us from really taking care of ourselves and really do the way that we are supposed to do that. Nature enables it because we probably wants too much. I don't know.  **Michelle Oravitz:** It's a too quick to, you know, quick fix. It's, it's going against the dao. It's going against that present moment, that being present because I, my theory or 'cause it wasn't really something that I specifically learned, but like, the more present you are, the more life force q you have because you, in this portal, your energy, your attention, like you said, no separation between the mind and the body. So the more present we are, the more energy could be here. If our minds are here and then it's somewhere else, or our bodies are just here and our minds somewhere else, we're scattered all over the place. [00:27:00] And, uh, so let's actually go back 'cause I thought that was really interesting what you were saying about the liver chi, like really, really severe liver cheese stagnation. Uh, for people listening, I've talked about the liver before, but liver cheese stagnation is severe stress. It's really being, to me it's kinda like being in major fight or flight chronically. **Jiaming Ju:** Mm-hmm. And it is interesting because the liver store is the blood. So some people will say like, especially, it's funny because I lived in New York for a long time and I will always spot a patient from New York, uh, from a mile away because whenever you ask them like, are you stressed? They're like, no, they look really stressed, but they're like, no, I can't handle it. This is intense Stress.  Handling it, you know,  doesn't  **Michelle Oravitz:** first of all, I lived in New York, so I know exactly what you're talking about. 'cause I'm a re recovering New Yorker. And then secondly ahead, I have a, like, I have a patient I could just picture in my head right now. I'm like, how are you doing? Everything's perfect. Everything's fine. Sleep is good. Good, good, good. Great. You know, and I'm like, she, and, [00:28:00] and then like every needle that goes in, oh, oh, you know, she's. **Jiaming Ju:** I think this is the hardest lesson in life. Um, I feel. Um, is to desire something and not getting it, like, either, not on your timeline or like not the way you want it. And I think, um, liver cheese stagnation is exactly that. I mean, traditionally we say, oh, it's anger is more manifested in road rage. But really in today's society, I like to interpret liver cheese technician manifested in ways. That is like a mild, like a irritability, like a constant irritability. You're just waiting people to, to do something wrong and you are snap at them, right? We are all familiar with that kind  **Michelle Oravitz:** It's resistance. It's resistance to life.  **Jiaming Ju:** frustration, right? You're like constantly frustrated. Someone [00:29:00] else got a promotion, you think you are deserve the promotion, you're not seeing anything frustration. It is. What you think in your head you deserve. And the reality, and there is a gross, like mismatching here. Um, and I, every single time I have a patient who comes because of, you know, infertility issues and I will always spend so much time talking to them about their psychology, like mental health. I, the way I do consultations. I have a huge part, at least I think. Total 30% of my total questions about the mental this matters in particular to people who have been having difficulty pregnant because, and I explain it to my patients like this, if you are so stagnant, if your body is so full of stagnation and cheat, where do you think a baby can sit? The baby. The baby has nowhere to sit. There is no room for the child. And [00:30:00] that in a way. Is indeed the hardest lesson because to be pregnant, to be a parent to me personally, I think is the hardest thing in life is, is the uncertainty. You can do everything you do. Right, right. In, in parenthood. You don't know how it's gonna turn out, and this is, this process actually start from getting pregnant. Like so many people feel so certain, oh, I just do it, you know, a couple of times. And during ovulation I will be pregnant. It doesn't work like that in Chinese medicine. You know, when it advocates for healthy pregnancy, it is the Jing, it is the Chi, it is the Ansys, it is the spirit and body of you and your partner.  **Michelle Oravitz:** Yep. **Jiaming Ju:** I'm not even a religious person, but I would say that is rather agno agno agnostic like process, right? Because it depends. You need a bit of luck For a [00:31:00] person who is intensely chi stagnant, they don't believe in luck. You, I'm, I don't know whether you've checked this with your patients,  **Michelle Oravitz:** yeah. No, they, they put everything on their shoulders. They think that it's all up to them, and that's why they feel like they need to control, and it's being in that fight or flight because you're in survival mode. And when you're in survival mode, there's not plenty to go around. You need to scrounge and you need to work, and you need to fight to get whatever you need. And that's, um, that's ultimately, you know, from an observer's perspective. Yeah, that's what I see. **Jiaming Ju:** Right. And it is, you will see whenever that happens, you know, it's almost like you as a provider, you are being told like. This is the only thing you're doing. You're, you're giving me a child and then like, this is never gonna work. This is never gonna work because liver cheese stagnation. Really, I feel like clinically is one of the major reasons for unexplained fertility. And that in turn frustrates the person even more because you're telling them structurally there is nothing wrong, [00:32:00] but they just cannot get pregnant no matter what they do. Right. Um, so this is already a deeply frustrating process and telling them that, leave it to. Just follow the protocol and leave it to fate. And you, I will always notice that 50, not 50%, like you always have like 20% of people or 30% of people who are just not, they'll ask you like, what are the best thing I can eat to make this happen faster? Right? Like, what, what is, um, you're going against what you, you know, you're, you're doing exactly the opposite of what you're supposed to. Um, but that is hard. I think  **Michelle Oravitz:** It is hard. Yeah. It, it's, it's one of those things that is often missed and I, I, I actually wrote a book about that. 'cause in the book I don't give any diet tips or anything. Like, I'm like, that's not what's needed. Because everybody can look up like the best diet and there's plenty of great books about what can help. And of course everybody's different and, you know, really understanding kind of your own sensitivities and et cetera. But. [00:33:00] My point is, is that many times people going through the fertility journey are actually very smart. They're very educated, and they educate themselves on. Supplements and what to do. And so they're, they, they have that down, but that's not what it's about. I mean, it's about also the nervous system and I, I say the nervous system 'cause it's more late layman terms, but it's ultimately what the QI does. Like the QI needs to move and to flow. And if we're in this fight or flight, it's stagnates. And so you see that often? **Jiaming Ju:** I think that's really true because it is really about the difficult, the most difficult thing in life is to dive into uncertainty.  **Michelle Oravitz:** Mm-hmm. **Jiaming Ju:** You have two types of people who, well, you have three types. One type who just like go with the flow, right? Nothing wrong with that. You have one type who always wanna get ahead before everybody else. They always wanna know everything that's supposed to be done, it comes to being pregnant, having a healthy delivery, [00:34:00] that's actually not how it works. And I think that's, you gotta have a openness. To say, I'm going to dive into this uncertainty because you know what, when a baby is here, when you have to raise this child, right, um, you're gonna need that when they start going to school or even when you homeschool them. It doesn't matter. Like you cannot control everything. And I think that is a very important thing that, uh, really starts even during pregnancy preparation.  **Michelle Oravitz:** You know, I will say it's kind of like meeting the love of your life  **Jiaming Ju:** Right,  **Michelle Oravitz:** and you're not like, you are gonna be the one that I marry. You know, you can't, you, it doesn't work like that. Then the person's gonna wanna run, run away.  **Jiaming Ju:** right. you. can't just come with your list and be like, well, You check every single list here. Right. Um.  **Michelle Oravitz:** it's gotta be a little more romantic and have those, you know, moments of quiet and silence and, and kind of have this dance [00:35:00] happen. **Jiaming Ju:** Yeah. But you know, I, I think the world has in increasingly, has increasingly become a place where. People want bandage solutions. And I think that where, uh, the economy, if you're looking at some like rising industries, that that's what it gives like, right? A product. This is especially the case in America where it's all about something has a product, right? Like what is the one-off solution you could give to that? But things where humans have been doing for centuries, like procreation. Defies the odd of that, no matter how many one-off Band-aid solutions you're gonna have, it's not going to click. And I keep telling this to all my patients who not only just for fertility, but for every odd syndromes under sun, as I have a lot of patients who have very difficult, complex disorders, [00:36:00] is that. When you commit to something that is trying to get pregnant or trying to get better, it's like when you go to a Taoist pimple or you go to any church or any religious place you go and you put a slice of your peace of your heart and peace of your mind there because you are really committed right in that given moment. And that's all I'm asking for as a provider. Um, I always don't always go into it with. But what about this? What about this? What about this? Like, why don't we settle this one first? Um, so, you know, talk about nervous system. You can come down first. Otherwise your nervous system is all over the place where you are like, you're not doing anything like, you know, fully. So.  **Michelle Oravitz:** And what other suggestions do you ever give people, um, suggestions that they could do outside of the. What you're helping [00:37:00] them with. Because I would typically say even like you can come in, do the acupuncture, even take the herbs and supplements. But if you're going back and having a crazy stressful time, then it's going to pretty much negate a lot of what we did. So I'll suggest things even like rounding or spending a little time in the morning of silence or peace just to kind of get themselves into a partnership really with me on their health. **Jiaming Ju:** Um. We have a 16 page behavior report that we customize for every single new patient, um, that I will hold 'em to it. That includes  nutrition and also lifestyle tips for people who try to get pregnant specifically. Um, I give, like, I consider this not as tips. I consider this as just like you need to do it is to get your [00:38:00] husband or your partner or whoever donates the sperm tested as soon as possible and making sure they're not drinking like six. Bottles of beer a day. Like, you know, like if you're in this like, you know, situation prep, pre uh, preparing for pregnancy, they should too. Um, and I usually advocate for morning intercourse rather than night intercourse. During ovulation to increase the chances. Um, and there are a bunch of specific ones. I usually give like on a patient to patient base, but I also will tell people to, um, spend at least one or two hours of, of a day to practice the Daoist principle of Uwe. **Michelle Oravitz:** I love that. That's my favorite, by the way.  **Jiaming Ju:** and I, you know, your New York patients will be like, no. But like, um, can I actually go cycling during that time? I'm like, no. The point of Uwe is you do nothing productive. [00:39:00] Then they have, you put them in a conundrum because they're like, then I'm just wasting my time. I'm like, no.  **Michelle Oravitz:** Wait, so people who don't know wwe, can you explain. **Jiaming Ju:** So WWE is the Daoist principle of doing nothing. Um, it's a practice I regularly issue to people to forcefully calm their mind. So I give a bunch of suggestions through what you can do for your wwe. Like for example, uh, you can knit, but not because. You're knitting for a nephew or something, you're learning to knit, not because you're good at it, it is because you want to. So it's to completely deviate from a lifestyle where we are chasing daily achievement all the time, right? It's more about resting your body and mind and focus on what matters on the present, which traditionally you to think it doesn't matter. So one of my favorite thing, even when I lived in New York City, was to really sit in a random coffee shop and just sit there, read my book or like judge [00:40:00] people's sense of fashion. So I will like people judge when I'm in the cafes. Like, what did you do during that time? Nothing. But I always feel like, great.  **Michelle Oravitz:** But it's like effortless effort. You're still there. It's not like you're totally inactive. You're, you're still there, but you're like in this neutral flow  state.  **Jiaming Ju:** Right, and then that's very important because there is nothing more difficult to a person who tries to get pregnant than thinking they're losing time. They're being told that they're losing time. They're late by every possible doctor under the sun. But you know, that is a time, is a, being late or not is a relative concept, as we say in Chinese medicine,  **Michelle Oravitz:** It's true. **Jiaming Ju:** So oftentimes you'll see people like signing off for IVF, not because they're physical ready, It's because they are told they are short on time, right? You don't do this now, you can't do it in three months. But statistics don't work like that. Like you said, you know, [00:41:00] within three months, your body's not going to dramatically change. You, you must well spend the time to take care of yourself, then really increase your chances rather than, I'm gonna dive into this when I'm super stressed. Um, pinning so much hope on this. Um, so yeah, again, I mean, I, I think that's really the thing, like having a child and being pregnant is not just something you must do in life. It's a, it's more than that. It's a mild, it's, it's, um. It's a face in life. One doesn't have to have it, but if you do decide to have it, I, I really think that people need to take a broader view on it.  **Michelle Oravitz:** 100%. I think that is so beautifully put because it is a big picture and it's um, you can't just take the part and then look at the part and say, okay, that's it. You have to look at like. How it interplays and works together as a [00:42:00] whole organism. And that's when you get the big picture. And, um, yeah. And I think about like, you know, the yin and the yang, you know, being too young all the time, you're gonna burn out the yin and that's ultimately the nervous system right there, having that balance. **Jiaming Ju:** Yeah, exactly. I think the society demands us to constantly deliver.  **Michelle Oravitz:** Mm-hmm. **Jiaming Ju:** The question is, what are you delivering? There isn't a return policy for a parent once the child is here. You are responsible for them for life. Um, so this is not just, I'm just, I just wanna get pregnant. This is a how it's going to completely transform your life wrecking you because your identity will be rewritten the minute you are pregnant, uh, when you become a parent. Um, and I think people need to probably, you know, take it, I always say like, take it more seriously, but [00:43:00] also take it less seriously. I. Because I think people take it really seriously on the, am I pregnant or not pregnant part, Right. But that don't take that too seriously, but like people need to consider what that means. The implication at your health more seriously.  **Michelle Oravitz:** Yeah, for sure. And so if people, and it's, it, it really helps to have somebody to work with because I think that. There's a lot of reminders that can be done from somebody who's looking at it more objectively and not in it because it's very hard to understand, um, what you're sharing if you're not working with somebody else. And I think that that's like the benefit on top of obviously getting the therapy, but also getting, you know, the treatments and also. Getting that perspective because when you're too in it, it's very hard to decipher. So I think that that is very priceless. Um, so for people who want to work with you, what do you offer? **Jiaming Ju:** [00:44:00] I think the, if you're interested in, and I always say this as a dare and those are kinds of my favorite tongue, tongue readings to do, is that people who say like, no, I won't tell you anything. I just give you my tongue, and then they're completely in shock when I spell out all your, their life secrets. So I think That's the number one thing you can do. Um, and in these tongue readings, I also give three quick suggestions, but I give a very good overview of like what you're not telling me about what's happening, wizard Health. Um, and that's a very fun thing to do. 'cause everyone has a tongue, right? And tongue reading is one of the most traditional things we offer in Chinese medicine. Uh, but usually the serious, more serious part. Is the one-on-one consultation with me online. And um, and then customized herbal formulation. I would say like 95% of my one-on-one patients on customized herbal formulation. And then. We do the monthly follow up for [00:45:00] that. And then there is also a bunch of digital small booklets, recipe books like that we, um, that I have written. For example, I have a postpartum recipe booklet that I highly recommend for anybody who is pregnant. And you don't know what, what really you heard about this myth about Chinese women eating different things postpartum. You don't know what that is. Uh, I wrote. A 20 page I believe, recipe book that  includes breakfast, lunch, and dinner and snack. Uh, for that. So That's a lot of like self study resources as well. Yeah, **Michelle Oravitz:** That's great. Um, sounds awesome. And you do raw herbs.  **Jiaming Ju:** no, I only do gran.  **Michelle Oravitz:** Oh, granule, which is so easy, but it also is effective because it's easy to digest, easier  **Jiaming Ju:** right. And everything is made to order. So we have patients from Scotland to, to Singapore. It's, it. is we, so it's, uh, everything is made to order and I co-write a formula with my dad for every single [00:46:00] patient. So,  **Michelle Oravitz:** Fantastic. And how can people find you? **Jiaming Ju:** Uh, you can follow us at Quinn House, KUN House. Uh, I believe we're on TikTok as well, but I never check TikTok. I'm a little bit scared of TikTok, so, um, Instagram is my  **Michelle Oravitz:** It's funny, I never got into TikTok too. I just do reels on Instagram. I just love Instagram. **Jiaming Ju:** Yeah, I think TikTok is a little bit of a wild scenario, but, um, yeah, Instagram is where I, I think do the most, so.  **Michelle Oravitz:** Awesome. Well, it was such a pleasure talking to you. You sound like a wealth of knowledge and I love your perspective and really how you understand, um, really from diet and, and also herbals, which is an art in itself. So thank you so much for coming on today. It was such a pleasure talking to you.  **Jiaming Ju:** you. [00:47:00]     

In this episode of 'Maximize Your Hunt', host Jon Teater discusses various aspects of hunting, including land management, habitat improvement, and the selection of deer rifles. Joined by expert Mark Cobb, they delve into the intricacies of choosing the right caliber and cartridge, the importance of gun fit, and the evaluation of new versus traditional cartridges. The conversation emphasizes practical considerations for hunters, such as shooting distance, accuracy, and the significance of comfort and familiarity with firearms. In this conversation, the speakers delve into various aspects of firearms, focusing on popular platforms, customization options, reloading techniques, and the importance of selecting the right caliber and ammunition. They discuss personal experiences with different firearms, emphasizing the significance of finding a balance between comfort, performance, and budget. The dialogue also highlights the necessity of quality optics and accessories to enhance shooting accuracy and overall experience. Takeaways: Maximizing hunting property involves effective land management. Choosing the right deer rifle is crucial for success. Don't get caught up in the latest trends in cartridges. The 270 Winchester is a reliable choice for deer hunting. Understanding shooting distance is key to selecting a rifle. Gun fit and comfort significantly impact shooting performance. Moderate recoil is important for effective hunting. Test driving a gun is akin to test driving a car. Consider the energy and velocity of bullets for effective hunting. A well-chosen cartridge can enhance hunting success. Bergara offers a range of firearms that cater to different budgets. Customization is key to achieving the best shooting experience. Reloading can significantly improve precision and performance. Choosing the right caliber is crucial for effective hunting. Quality optics can greatly enhance shooting accuracy. A one MOA gun is ideal for deer hunting. Practice is essential for proficiency in shooting. Understanding the harmonics of a barrel can improve accuracy. Selecting the right accessories can impact shooting performance. Personal experience and research are vital in firearm selection.   Social Links https://whitetaillandscapes.com/ https://www.facebook.com/whitetaillandscapes/ https://www.instagram.com/whitetail_landscapes/?hl=en Learn more about your ad choices. Visit megaphone.fm/adchoices